Brainstorm Cell Therapeutics shares owned by Bnp Paribas Arbitrage, Snc
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Bnp Paribas Arbitrage, Snc
from 13F filings
Historical chart of Bnp Paribas Arbitrage, Snc investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Brainstorm Cell Therapeutics by Bnp Paribas Arbitrage, Snc
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $99 | 364 | 0.27 |
2023-09-30 | $72 | 364 | 0.20 |
2023-06-30 | $749 | 364 | 2.06 |
2023-03-31 | $1.2k | 364 | 3.30 |
2022-12-31 | $596 | 364 | 1.64 |
2022-09-30 | $1.6k | 364 | 4.42 |
2022-06-30 | $1.0k | 364 | 2.76 |
2022-03-31 | $1.6k | 481 | 3.36 |
2021-12-31 | $1.9k | 481 | 4.00 |
2021-09-30 | $113k | 6.7k | 16.92 |
2021-06-30 | $7.2k | 1.9k | 3.80 |
2021-03-31 | $16k | 4.1k | 3.83 |
2020-12-31 | $28k | 6.1k | 4.52 |
2020-09-30 | $113k | 6.7k | 16.92 |
2020-06-30 | $11k | 999 | 11.21 |
More positions owned by Bnp Paribas Arbitrage, Snc
Visa Equity (V)
View all positions for Bnp Paribas Arbitrage, Snc